← Back to Search

Dietary Supplement

Nutritional Snacks for Dementia

N/A
Recruiting
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has a medical diagnosis of dementia or possible dementia
Be older than 18 years old
Must not have
Requires 100% feeding assistance
Cannot participate in the protocol independently and do not have a consistent caregiver who can provide assistance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether or not a new type of snack food, which starts as one texture and changes to another, can help improve the nutritional intake of adults with dementia.

Who is the study for?
This trial is for stable adults living at home with a medical diagnosis of dementia or possible dementia. They must be able to participate in the study protocol on their own or have a caregiver who can assist, and they need smartphone access. People who require full feeding assistance, are NPO (nothing by mouth), have multiple food allergies, or need strict renal, low-fat/no-salt diets cannot join.
What is being tested?
The study tests if transitional-state snacks—foods that change texture—can improve nutrition in people with dementia. These savory snacks resemble regular foods and aim to enhance physical and cognitive health by improving dietary intake.
What are the potential side effects?
While specific side effects aren't listed, potential risks may include choking hazards or allergic reactions if participants react to snack ingredients. Safety will be monitored closely given the vulnerability of individuals with dementia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with dementia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need help with all my feeding.
Select...
I can participate on my own or have a caregiver to assist me.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in acceptability of nutrition supplements
Number of test snacks consumed each week
Participant enrollment rates (%)
+2 more
Secondary study objectives
Change in calcium intake (mg/d)
Change in carbohydrate intake (g/d)
Change in daily energy intake (kcal/d)
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Oregon Partnership for Alzheimer's ResearchUNKNOWN
1 Previous Clinical Trials
3 Total Patients Enrolled
University of OregonLead Sponsor
85 Previous Clinical Trials
44,218 Total Patients Enrolled
1 Trials studying Dementia
250 Patients Enrolled for Dementia
Oregon Health and Science UniversityOTHER
1,006 Previous Clinical Trials
7,413,899 Total Patients Enrolled
13 Trials studying Dementia
1,483 Patients Enrolled for Dementia

Media Library

Transitional-state food therapeutic nutrition supplement (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05007730 — N/A
Dementia Research Study Groups: Intervention Arm
Dementia Clinical Trial 2023: Transitional-state food therapeutic nutrition supplement Highlights & Side Effects. Trial Name: NCT05007730 — N/A
Transitional-state food therapeutic nutrition supplement (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05007730 — N/A
~0 spots leftby Dec 2024